ARALEZ PHARMACEUTICALS INC. Business Acquisition, Pro Forma Earnings Per Share, Basic
ARALEZ PHARMACEUTICALS INC. reported Business Acquisition, Pro Forma Earnings Per Share, Basic of -$0.25 per share for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic · last filed 2016-08-09
- ARALEZ PHARMACEUTICALS INC. business acquisition, pro forma earnings per share, basic for the quarter ending 2016-06-30 was -$0.25.
- ARALEZ PHARMACEUTICALS INC. business acquisition, pro forma earnings per share, basic for the quarter ending 2016-03-31 was -$0.32.
- ARALEZ PHARMACEUTICALS INC. business acquisition, pro forma earnings per share, basic for the quarter ending 2015-06-30 was -$0.33.
- ARALEZ PHARMACEUTICALS INC. business acquisition, pro forma earnings per share, basic for the quarter ending 2015-03-31 was -$0.54.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Basic 3 month | Business Acquisition, Pro Forma Earnings Per Share, Basic 6 month |
|---|---|---|
| 2016-06-30 | -$0.25 10-Q · filed 2016-08-09 | -$0.56 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$0.32 10-Q · filed 2016-05-10 | |
| 2015-06-30 | -$0.33 10-Q · filed 2016-08-09 | -$0.92 10-Q · filed 2016-08-09 |
| 2015-03-31 | -$0.54 10-Q · filed 2016-05-10 |